MedTrace Logo

Cost-effectiveness Evaluation of Robotic Surgery in the Removal of Lung Lesions in the ATS of Milan

NCT05674227 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5400

Last updated 2023-02-01

No results posted yet for this study

Summary

The goal of this observational study is to compare cost-effectiveness of robotic surgery with open surgery and video-assisted thoracoscopy surgery (VATS) in adult patients, resident in the ATS of Milan area, operated for lung cancer.

The main question it aims to answer is:

• Is the robotic surgery cost-effective compared with thoracotomy and VATS in the surgical treatment of operable lung cancers in the adult population of the ATS of Milan?

Researchers will compare robotic surgery with open and VAT surgery of operable lung cancer to see if robotic surgery performs better in terms of cost per year of life gained or in terms of cost per quality of life earned.

Conditions

Interventions

PROCEDURE

Robotic surgery

Surgical treatment of operable lung cancers using robotic systems

PROCEDURE

Video-assisted thoracoscopy

Surgical treatment of operable lung cancers using a video-assisted thoracoscopy approach (VAT)

PROCEDURE

Open surgery

Surgical treatment of operable lung cancers using open surgery

Sponsors & Collaborators

  • Istituto Europeo di Oncologia

    collaborator OTHER

  • Humanitas Hospital, Italy

    collaborator OTHER

  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

    collaborator OTHER

  • Ospedale San Raffaele

    collaborator OTHER

  • ASST Grande Ospedale Metropolitano Niguarda

    collaborator OTHER

  • Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

    collaborator OTHER

  • ASST Ovest Milanese, Ospedale Nuovo di Legnano

    collaborator UNKNOWN

  • IRCCS Multimedica

    collaborator OTHER

  • Agenzia di Tutela della Salute della Città Metropolitana di Milano

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2023-08-31
Completion
2023-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05674227 on ClinicalTrials.gov